ArticleChronic respiratory disease2018
Relationship between lung function and inhalation devices for LAMA/LABA therapy for chronic obstructive pulmonary disease.
Hideyasu Yamada, Norihito Hida, Hiroaki Satoh, Taisuke Nakaizumi, Hideo Terashima, Nobuyuki Hizawa
Open access · goldAbstract readLetter
In one paragraphArticle in Chronic respiratory disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 74% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
6 authors at 4 institutions in 1 country.
Hideyasu Yamada1 Hitachinaka Medical Education and Research Center, University of Tsukuba Hospital, 20-1 Ishikawa-cho, Hitachinaka-shi, Ibaraki 312-0057, Japan.
Norihito Hida3 Department of Respiratory Medicine, Hitachi Hitachinaka General Hospital, 20-1 Ishikawa-cho, Hitachinaka-shi, Ibaraki 312-0057, Japan.
Hiroaki Satoh2 Department of Pulmonology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki 305-8577, Japan.
Taisuke Nakaizumi3 Department of Respiratory Medicine, Hitachi Hitachinaka General Hospital, 20-1 Ishikawa-cho, Hitachinaka-shi, Ibaraki 312-0057, Japan.
Hideo Terashima1 Hitachinaka Medical Education and Research Center, University of Tsukuba Hospital, 20-1 Ishikawa-cho, Hitachinaka-shi, Ibaraki 312-0057, Japan.
Nobuyuki Hizawa2 Department of Pulmonology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Ibaraki 305-8577, Japan.
Hitachi General Hospital · JPUniversity of Tsukuba Hospital · JPNational Hospital Organization Mito Medical Center · JPUniversity of Tsukuba · JP
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Dry Powder InhalersAdrenergic beta-2 Receptor AgonistsAgedAged, 80 and overBenzoxazinesDelayed-Action PreparationsDrug CombinationsForced Expiratory VolumeGlycopyrrolateHumansIndansMaleMuscarinic AntagonistsPulmonary Disease, Chronic ObstructiveQuinolonesTiotropium BromideAdrenergic beta-2 Receptor AgonistsBenzoxazinesDelayed-Action PreparationsDrug CombinationsGlycopyrrolateindacaterolIndansMuscarinic AntagonistsolodaterolQuinolonesTiotropium BromideChronic obstructive pulmonary diseaseDry-powder inhalersLong-acting muscarinic antagonistLong-acting β2 agonistSoft-mist inhalers
Identifiers
PMID29152998
PMCPMC6234572
OpenAlexW2768641908
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390